{"entity":{"type":"insider","cik":"0001555918","url":"/insider/0001555918","json_url":"/insider/0001555918.json","name":"Gibson Neil W","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":14,"first":"2014-01-17","last":"2020-03-27","span_basis":"filed_date"},"name_variants":[{"name":"Gibson Neil W","source":"filing","n_filings":14,"first_seen":"2014-01-17","last_seen":"2020-03-27"}],"transactions":[{"id":3039875,"accession":"0001209191-20-021385","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-20-021385","line_url":"/filing/0001209191-20-021385#line-9","is_derivative":false,"issuer_cik":"0001555918","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001555918","owner_cik":"0001555918","owner_name":"Gibson Neil W","owner_display_name":"Gibson Neil W","owner_url":"/insider/0001555918","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":648.0,"shares_display":"648","price_per_share":7.94,"price_display":"7.94","price_state":"stated","total_value":5145.12,"total_display":"5,145.12","total_whole":"5,145","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-20","filed_date":"2020-03-27","scope":"insider"},{"id":3039873,"accession":"0001209191-20-021385","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-20-021385","line_url":"/filing/0001209191-20-021385#line-8","is_derivative":false,"issuer_cik":"0001555918","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001555918","owner_cik":"0001555918","owner_name":"Gibson Neil W","owner_display_name":"Gibson Neil W","owner_url":"/insider/0001555918","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3140.0,"shares_display":"3,140","price_per_share":7.41,"price_display":"7.41","price_state":"stated","total_value":23267.4,"total_display":"23,267.40","total_whole":"23,267","shares_owned_after":648.0,"shares_owned_after_display":"648","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-19","filed_date":"2020-03-27","scope":"insider"},{"id":3039870,"accession":"0001209191-20-021385","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-021385","line_url":"/filing/0001209191-20-021385#line-7","is_derivative":false,"issuer_cik":"0001555918","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001555918","owner_cik":"0001555918","owner_name":"Gibson Neil W","owner_display_name":"Gibson Neil W","owner_url":"/insider/0001555918","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3120.0,"shares_display":"3,120","price_per_share":6.83,"price_display":"6.83","price_state":"stated","total_value":21309.6,"total_display":"21,309.60","total_whole":"21,310","shares_owned_after":3788.0,"shares_owned_after_display":"3,788","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-18","filed_date":"2020-03-27","scope":"insider"},{"id":3039868,"accession":"0001209191-20-021385","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-021385","line_url":"/filing/0001209191-20-021385#line-6","is_derivative":false,"issuer_cik":"0001555918","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001555918","owner_cik":"0001555918","owner_name":"Gibson Neil W","owner_display_name":"Gibson Neil W","owner_url":"/insider/0001555918","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3009.0,"shares_display":"3,009","price_per_share":6.49,"price_display":"6.49","price_state":"stated","total_value":19528.41,"total_display":"19,528.41","total_whole":"19,528","shares_owned_after":6908.0,"shares_owned_after_display":"6,908","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-17","filed_date":"2020-03-27","scope":"insider"},{"id":3039865,"accession":"0001209191-20-021385","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-021385","line_url":"/filing/0001209191-20-021385#line-5","is_derivative":false,"issuer_cik":"0001555918","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001555918","owner_cik":"0001555918","owner_name":"Gibson Neil W","owner_display_name":"Gibson Neil W","owner_url":"/insider/0001555918","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17723.0,"shares_display":"17,723","price_per_share":6.604,"price_display":"6.60","price_state":"stated","total_value":117042.692,"total_display":"117,042.69","total_whole":"117,043","shares_owned_after":9917.0,"shares_owned_after_display":"9,917","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-27","scope":"insider"},{"id":3039863,"accession":"0001209191-20-021385","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-021385","line_url":"/filing/0001209191-20-021385#line-4","is_derivative":false,"issuer_cik":"0001555918","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001555918","owner_cik":"0001555918","owner_name":"Gibson Neil W","owner_display_name":"Gibson Neil W","owner_url":"/insider/0001555918","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52000.0,"shares_display":"52,000","price_per_share":6.5172,"price_display":"6.52","price_state":"stated","total_value":338894.4,"total_display":"338,894.40","total_whole":"338,894","shares_owned_after":27640.0,"shares_owned_after_display":"27,640","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-13","filed_date":"2020-03-27","scope":"insider"},{"id":8456998,"accession":"0001209191-15-008000","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-008000","line_url":"/filing/0001209191-15-008000","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001555918","owner_name":"Gibson Neil W","owner_display_name":"Gibson Neil W","owner_url":"/insider/0001555918","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":18.05380521875,"price_display":"18.05","price_state":"stated","total_value":1444304.4175,"total_display":"1,444,304.42","total_whole":"1,444,304","shares_owned_after":8655.0,"shares_owned_after_display":"8,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-28","filed_date":"2015-01-30","scope":"insider","n_lines":2},{"id":6742469,"accession":"0001209191-14-071942","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-071942","line_url":"/filing/0001209191-14-071942","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001555918","owner_name":"Gibson Neil W","owner_display_name":"Gibson Neil W","owner_url":"/insider/0001555918","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":19.298,"price_display":"19.30","price_state":"stated","total_value":48245.0,"total_display":"48,245.00","total_whole":"48,245","shares_owned_after":80000.0,"shares_owned_after_display":"80,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-28","filed_date":"2014-12-01","scope":"insider","n_lines":2},{"id":6768996,"accession":"0001209191-14-065581","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-065581","line_url":"/filing/0001209191-14-065581","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001555918","owner_name":"Gibson Neil W","owner_display_name":"Gibson Neil W","owner_url":"/insider/0001555918","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":19.2936,"price_display":"19.29","price_state":"stated","total_value":48234.0,"total_display":"48,234.00","total_whole":"48,234","shares_owned_after":80200.0,"shares_owned_after_display":"80,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-29","filed_date":"2014-10-31","scope":"insider","n_lines":3},{"id":6709279,"accession":"0001209191-14-064729","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-064729","line_url":"/filing/0001209191-14-064729#line-2","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001555918","owner_name":"Gibson Neil W","owner_display_name":"Gibson Neil W","owner_url":"/insider/0001555918","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":14.4376,"price_display":"14.44","price_state":"stated","total_value":47644.08,"total_display":"47,644.08","total_whole":"47,644","shares_owned_after":80000.0,"shares_owned_after_display":"80,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-22","filed_date":"2014-10-24","scope":"insider"},{"id":6679430,"accession":"0001209191-14-057928","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-057928","line_url":"/filing/0001209191-14-057928#line-4","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001555918","owner_name":"Gibson Neil W","owner_display_name":"Gibson Neil W","owner_url":"/insider/0001555918","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":8.0075,"price_display":"8.01","price_state":"stated","total_value":17616.5,"total_display":"17,616.50","total_whole":"17,617","shares_owned_after":80000.0,"shares_owned_after_display":"80,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-12","filed_date":"2014-09-15","scope":"insider"},{"id":6679423,"accession":"0001209191-14-057928","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-057928","line_url":"/filing/0001209191-14-057928#line-2","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001555918","owner_name":"Gibson Neil W","owner_display_name":"Gibson Neil W","owner_url":"/insider/0001555918","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":8.005,"price_display":"8.00","price_state":"stated","total_value":16010.0,"total_display":"16,010.00","total_whole":"16,010","shares_owned_after":80000.0,"shares_owned_after_display":"80,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-11","filed_date":"2014-09-15","scope":"insider"},{"id":6266927,"accession":"0001209191-14-045271","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-045271","line_url":"/filing/0001209191-14-045271#line-2","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001555918","owner_name":"Gibson Neil W","owner_display_name":"Gibson Neil W","owner_url":"/insider/0001555918","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":8.104,"price_display":"8.10","price_state":"stated","total_value":20260.0,"total_display":"20,260.00","total_whole":"20,260","shares_owned_after":80000.0,"shares_owned_after_display":"80,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-01","filed_date":"2014-07-02","scope":"insider"},{"id":6559422,"accession":"0001209191-14-042422","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-042422","line_url":"/filing/0001209191-14-042422#line-2","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001555918","owner_name":"Gibson Neil W","owner_display_name":"Gibson Neil W","owner_url":"/insider/0001555918","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":8.0454,"price_display":"8.05","price_state":"stated","total_value":40227.0,"total_display":"40,227.00","total_whole":"40,227","shares_owned_after":80000.0,"shares_owned_after_display":"80,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-17","filed_date":"2014-06-18","scope":"insider"},{"id":6492427,"accession":"0001209191-14-026952","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-026952","line_url":"/filing/0001209191-14-026952#line-2","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001555918","owner_name":"Gibson Neil W","owner_display_name":"Gibson Neil W","owner_url":"/insider/0001555918","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":8.1085,"price_display":"8.11","price_state":"stated","total_value":20271.25,"total_display":"20,271.25","total_whole":"20,271","shares_owned_after":80000.0,"shares_owned_after_display":"80,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-09","filed_date":"2014-04-10","scope":"insider"},{"id":6471075,"accession":"0001209191-14-018177","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-018177","line_url":"/filing/0001209191-14-018177#line-2","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001555918","owner_name":"Gibson Neil W","owner_display_name":"Gibson Neil W","owner_url":"/insider/0001555918","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":11.3714,"price_display":"11.37","price_state":"stated","total_value":28428.5,"total_display":"28,428.50","total_whole":"28,429","shares_owned_after":80000.0,"shares_owned_after_display":"80,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-06","filed_date":"2014-03-07","scope":"insider"},{"id":6612451,"accession":"0001209191-14-008310","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-008310","line_url":"/filing/0001209191-14-008310#line-2","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001555918","owner_name":"Gibson Neil W","owner_display_name":"Gibson Neil W","owner_url":"/insider/0001555918","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":8.3832,"price_display":"8.38","price_state":"stated","total_value":146706.0,"total_display":"146,706.00","total_whole":"146,706","shares_owned_after":35000.0,"shares_owned_after_display":"35,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-05","filed_date":"2014-02-07","scope":"insider"},{"id":6374699,"accession":"0001209191-14-004526","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-004526","line_url":"/filing/0001209191-14-004526#line-2","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001555918","owner_name":"Gibson Neil W","owner_display_name":"Gibson Neil W","owner_url":"/insider/0001555918","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4421.0,"shares_display":"4,421","price_per_share":8.0896,"price_display":"8.09","price_state":"stated","total_value":35764.1216,"total_display":"35,764.12","total_whole":"35,764","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-21","filed_date":"2014-01-23","scope":"insider"},{"id":6966770,"accession":"0001209191-14-004014","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-004014","line_url":"/filing/0001209191-14-004014#line-3","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001555918","owner_name":"Gibson Neil W","owner_display_name":"Gibson Neil W","owner_url":"/insider/0001555918","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4479.0,"shares_display":"4,479","price_per_share":8.1477,"price_display":"8.15","price_state":"stated","total_value":36493.5483,"total_display":"36,493.55","total_whole":"36,494","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-17","filed_date":"2014-01-21","scope":"insider"},{"id":6521650,"accession":"0001209191-14-003657","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-003657","line_url":"/filing/0001209191-14-003657#line-2","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001555918","owner_name":"Gibson Neil W","owner_display_name":"Gibson Neil W","owner_url":"/insider/0001555918","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":8.0336,"price_display":"8.03","price_state":"stated","total_value":8836.96,"total_display":"8,836.96","total_whole":"8,837","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-16","filed_date":"2014-01-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001750019","name":"TCR2 THERAPEUTICS INC.","url":"/issuer/0001750019","role":"Director","n_filings":1,"first_seen":"2020-03-27","last_seen":"2020-03-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001505512","name":"Regulus Therapeutics Inc.","url":"/issuer/0001505512","role":"Officer (Chief Scientific Officer)","n_filings":13,"first_seen":"2014-01-17","last_seen":"2015-01-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001555918","retrieved_at":"2026-08-27T09:23:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}